Kukje launches losatan generic

Published: 2009-02-18 06:57:00

Updated: 2009-02-18 06:57:00

Kukje Pharm says it has launched Lozaltan tablet, generic product of Cozaar (losartan) marketed by the U.S. pharmaceutical firm Merck & Co.

The domestic losartan market is valued at 40 billion won.

Losartan is a selective, competitive angiotensin II receptor type 1 (AT1) receptor antagonist...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK